DZNep, as an EZH2 inhibitor, has a significant inhibitory effect on cell clonogenesis in both human and mouse AML cell lines and has an antileukemia effect in leukemia mouse models, accompanied by upregulated expression of tumor suppressor genes CDKN lA and FBX032 [5]. This evidence concerns the gene EZH2 and acute myeloid leukemia.